Bittium (BITTI) investor relations material

Strategic Direction and Growth Ambitions

• The updated strategy accelerates international growth, leveraging a strong balance sheet, technological leadership, and a shift from R&D-centric to customer-centric operations, with a focus on defense, security, medical, and engineering segments.

• Four strategic pillars: international sales and partnerships, technological leadership (including AI/software), expansion to new markets/verticals (with inorganic growth), and transformation to a data-driven, scalable operational model.

• Emphasis on strategic partnerships, selective M&A, and investments in scaling business and international sales channels to complement the product portfolio and access new markets.

• Acquisition of a stake in Marshall.ai to integrate advanced AI into tactical communications and medical devices, enabling on-device AI without cloud connectivity.

• All business segments—Defense & Security, Medical, and Engineering Services—are positioned for growth under the new strategy, leveraging technology, AI, and strategic partnerships.

Financial Guidance and Targets

• 2024 guidance: net sales €95–105 million, operating profit €13 million, with a strong growth trend, especially in defense and security.

• Net sales for 2025 are expected to reach €95–105 million, up from €85.2 million in 2024, with operating result for 2025 forecast at €10–13 million.

• Long-term financial targets raised: annual net sales growth of 20–30% and operating profit margin of 10–20%, with growth expected from both organic and inorganic sources.

• Dividend policy remains unchanged, balancing profit distribution with growth financing needs, and considers net income, financial situation, and capital needs.

• R&D investments have decreased from over 30% to 16% of revenue, expected to remain at 15–20% as business scales, with 15.9% of net sales allocated in 2024.

Business Segment Highlights

• Defense & Security: 60% of revenue, 42% growth in 2024, focus on next-gen tactical communications, AI integration, and expanding international sales, especially in NATO and allied countries.

• Medical: 23% of revenue, focus narrowed to cardiac (EKG) and sleep apnea (HSAT), leveraging gold-standard Pharos device, strategic partnerships, and US market entry.

• Engineering Services: 17% of revenue, focus on wireless connectivity, embedded devices, embedded AI, and productized services, targeting defense OEMs in Europe.

• All segments benefit from strong market drivers such as geopolitical tensions, healthcare digitalization, and IoT growth.

• Strategic partnerships and M&A are being explored to accelerate market entry and complement capabilities.